JANA Partners 13F holdings, Q3 2016
Holdings as of September 30, 2016 · filings on SEC EDGAR · latest filing →
JANA Partners disclosed 42 US equity positions worth $4.8bn in its Q3 2016 13F filing. The largest position was CAG at 17.6% of the reported book, followed by 8L8C and WTW. Against the Q2 2016 filing, it opened 27 new positions, added to 6 and reduced 7 among the top 42 holdings.
What did JANA Partners own in Q3 2016? Top 42 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2016 |
|---|---|---|---|---|---|---|---|
| 1 | CAG CONAGRA FOODS INC | Consumer Defensive | 17.6% | $837.9m | 17,786,352 | -1% | reduced |
| 2 | 8L8C LIBERTY BROADBAND CORP | 9.5% | $454.0m | 6,351,335 | -31% | reduced | |
| 3 | WTW WILLIS TOWERS WATSON PUB LTD | Financial Services | 5.9% | $280.3m | 2,111,279 | 60% | added |
| 4 | HD SUPPLY HLDGS INC | 5.6% | $266.5m | 8,332,699 | 178% | added | |
| 5 | JCI JOHNSON CTLS INTL PLC | Industrials | 5.5% | $260.5m | 5,598,283 | – | new |
| 6 | COMPUTER SCIENCES CORP | 5.2% | $246.1m | 4,712,751 | 53% | added | |
| 7 | HARRIS CORP DEL | 4.7% | $221.7m | 2,420,000 | 10% | added | |
| 8 | COCA COLA EUROPEAN PARTNERS | 4.3% | $205.5m | 5,149,436 | -37% | reduced | |
| 9 | TEAM HEALTH HOLDINGS INC | 4.0% | $191.8m | 5,890,368 | 0% | held | |
| 10 | MPC MARATHON PETE CORP | Energy | 3.7% | $177.9m | 4,382,177 | 61% | added |
| 11 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 3.3% | $156.9m | 1,273,646 | – | new |
| 12 | HPE HEWLETT PACKARD ENTERPRISE C | Technology | 3.3% | $155.2m | 6,822,274 | 68% | added |
| 13 | PRICELINE GRP INC | 3.3% | $155.1m | 105,409 | – | new | |
| 14 | GOOG ALPHABET INC | Communication Services | 3.2% | $152.4m | 196,023 | -62% | reduced |
| 15 | MDLZ MONDELEZ INTL INC | Consumer Defensive | 3.1% | $145.3m | 3,310,023 | – | new |
| 16 | DELL DELL TECHNOLOGIES INC | Technology | 3.0% | $144.5m | 3,023,842 | – | new |
| 17 | GPK GRAPHIC PACKAGING HLDG CO | Consumer Cyclical | 3.0% | $143.8m | 10,280,060 | -1% | reduced |
| 18 | CSRA INC | 2.7% | $129.8m | 4,825,117 | -15% | reduced | |
| 19 | VIAB VIACOM INC NEW | 2.2% | $105.3m | 2,764,768 | – | new | |
| 20 | TIME INC NEW | 1.5% | $72.4m | 4,999,929 | 0% | held | |
| 21 | TWITTER INC | 1.4% | $67.9m | 2,945,866 | – | new | |
| 22 | SELECT MED HLDGS CORP | 0.5% | $25.6m | 1,896,554 | – | new | |
| 23 | VVV VALVOLINE INC | Consumer Cyclical | 0.5% | $24.7m | 1,049,700 | – | new |
| 24 | MONSANTO CO NEW | 0.4% | $20.4m | 200,000 | – | new | |
| 25 | KATE SPADE & CO | 0.4% | $18.3m | 1,066,833 | – | new | |
| 26 | XLE SELECT SECTOR SPDR TR | 0.2% | $10.1m | 143,000 | – | new | |
| 27 | SPY SPDR S&P 500 ETF TR | 0.2% | $9.4m | 43,500 | – | new | |
| 28 | YAHOO INC | 0.2% | $8.6m | 199,070 | – | new | |
| 29 | PATHEON N V | 0.2% | $7.2m | 243,271 | – | new | |
| 30 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.1% | $5.7m | 80,125 | – | new |
| 31 | GWPH GW PHARMACEUTICALS PLC | 0.1% | $5.5m | 41,600 | – | new | |
| 32 | INCY INCYTE CORP | Healthcare | 0.1% | $5.5m | 58,385 | – | new |
| 33 | NUVASIVE INC | 0.1% | $5.4m | 80,744 | – | new | |
| 34 | SG7 SAGE THERAPEUTICS INC | 0.1% | $5.1m | 111,127 | – | new | |
| 35 | PBYI PUMA BIOTECHNOLOGY INC | Healthcare | 0.1% | $5.1m | 76,074 | – | new |
| 36 | DERMIRA INC | 0.1% | $5.1m | 149,457 | – | new | |
| 37 | RADIUS HEALTH INC | 0.1% | $5.0m | 92,394 | – | new | |
| 38 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 0.1% | $4.9m | 52,890 | – | new |
| 39 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 0.1% | $4.9m | 96,210 | – | new |
| 40 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.1% | $4.7m | 149,252 | – | new |
| 41 | USFD US FOODS HLDG CORP | Consumer Defensive | 0.1% | $3.6m | 152,500 | -68% | reduced |
| 42 | ADVANCEPIERRE FOODS HLDGS IN | 0.0% | $2.1m | 74,900 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.